Harisons Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 23-06-2024
- Paid Up Capital ₹ 0.50 M
as on 23-06-2024
- Company Age 28 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.65 Cr
as on 23-06-2024
- Satisfied Charges ₹ 7.00 M
as on 23-06-2024
- Revenue 0.61%
(FY 2020)
- Profit -35.33%
(FY 2020)
- Ebitda -5.50%
(FY 2020)
- Net Worth 16.88%
(FY 2020)
- Total Assets -27.57%
(FY 2020)
About Harisons Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.65 Cr. The company has closed loans amounting to ₹7.00 M, as per Ministry of Corporate Affairs (MCA) records.
Dinesh Rawat, Nanu Bajaj, and Deepak Bajaj serve as directors at the Company.
- CIN/LLPIN
U24239CH1996PLC018334
- Company No.
018334
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 Jun 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationU T, Chandigarh
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Harisons Pharmaceuticals Limited offer?
Harisons Pharmaceuticals Limited offers a wide range of products and services, including Arthritic Drugs, Dexamethasone Injection, Sexual Wellness Products, Fertility Enhancer, Veterinary Injections, Vitamin & Multivitamin Injections, Vitamin D Injection, Common Disease Medicines, Pharmaceutical Medicine, Methylcobalamin Injection.
Who are the key members and board of directors at Harisons Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Rawat  | Director | 08-Nov-2012 | Current |
| Nanu Bajaj | Director | 01-Jul-2002 | Current |
| Deepak Bajaj | Director | 01-Jul-2002 | Current |
Financial Performance of Harisons Pharmaceuticals.
Harisons Pharmaceuticals Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 0.61% increase. The company also saw a substantial fall in profitability, with a 35.33% decrease in profit. The company's net worth Soared by an impressive increase of 16.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Harisons Pharmaceuticals?
In 2020, Harisons Pharmaceuticals had a promoter holding of 92.24% and a public holding of 7.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Pumjab & Sind Bank Creation Date: 03 Mar 2011 | ₹1.25 Cr | Open |
State Bank Of India Creation Date: 16 Aug 2005 | ₹4.00 M | Open |
Indian Overseas Bank Creation Date: 29 Jul 2009 | ₹7.00 M | Satisfied |
How Many Employees Work at Harisons Pharmaceuticals?
Unlock and access historical data on people associated with Harisons Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Harisons Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Harisons Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
